| 101 |
32574272 | Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets? | 2020 |
2 |
| 102 |
32574273 | Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection? | 2020 |
1 |
| 103 |
32582302 | Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes. | 2020 |
1 |
| 104 |
32589459 | Ocular Surface Expression of SARS-CoV-2 Receptors. | 2020 Jul 3 |
1 |
| 105 |
32595355 | Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target. | 2020 |
1 |
| 106 |
32638018 | Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. | 2020 Aug 1 |
1 |
| 107 |
32641482 | LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2. | 2020 Aug 31 |
1 |
| 108 |
32661206 | Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human. | 2020 |
1 |
| 109 |
32662421 | Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? | 2020 Jul 14 |
1 |
| 110 |
32664949 | SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis. | 2020 Jul 14 |
1 |
| 111 |
32726128 | Sex-derived attributes contributing to SARS-CoV-2 mortality. | 2020 Sep 1 |
1 |
| 112 |
32730844 | Structure-based drug repositioning over the human TMPRSS2 protease domain: search for chemical probes able to repress SARS-CoV-2 Spike protein cleavages. | 2020 Oct 1 |
2 |
| 113 |
32741259 | Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies. | 2020 Aug 3 |
1 |
| 114 |
32743585 | Neonatal hyperoxia enhances age-dependent expression of SARS-CoV-2 receptors in mice. | 2020 Jul 22 |
1 |
| 115 |
32768580 | Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2. | 2020 Oct 15 |
1 |
| 116 |
32808185 | Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue. | 2020 Dec |
1 |
| 117 |
32829149 | Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2. | 2020 Nov |
2 |
| 118 |
32857620 | Azithromycin Downregulates Gene Expression of IL-1β and Pathways Involving TMPRSS2 and TMPRSS11D Required by SARS-CoV-2. | 2020 Nov |
1 |
| 119 |
32864545 | The Resilient Child: Sex-Steroid Hormones and COVID-19 Incidence in Pediatric Patients. | 2020 Sep 1 |
1 |
| 120 |
32890967 | Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19. | 2020 Nov |
1 |
| 121 |
32960480 | Ethnic differences in alpha-1 antitrypsin deficiency allele frequencies may partially explain national differences in COVID-19 fatality rates. | 2020 Nov |
2 |
| 122 |
32985199 | Immunotherapy approaches on innate immunity for SARS-Cov-2. | 2020 |
1 |
| 123 |
32992731 | Impact of Comorbidities on SARS-CoV-2 Viral Entry-Related Genes. | 2020 Sep 25 |
2 |
| 124 |
33042994 | Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System. | 2020 |
1 |
| 125 |
33052338 | Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2. | 2020 Oct 7 |
3 |
| 126 |
33125431 | Kidney ACE2 expression: Implications for chronic kidney disease. | 2020 |
1 |
| 127 |
33137894 | Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies. | 2020 Oct 29 |
4 |
| 128 |
33193689 | TMPRSS2 Correlated With Immune Infiltration Serves as a Prognostic Biomarker in Prostatic Adenocarcinoma: Implication for the COVID-2019. | 2020 |
4 |
| 129 |
33218024 | Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model. | 2020 Nov 18 |
1 |
| 130 |
33278189 | Is Spironolactone the Preferred Renin-Angiotensin-Aldosterone Inhibitor for Protection Against COVID-19? | 2020 Dec 4 |
1 |
| 131 |
33290397 | Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection. | 2020 Dec |
1 |
| 132 |
33328008 | [A review on the role of angiotensin-converting enzyme 2 in children with coronavirus disease 2019]. | 2020 Dec |
1 |
| 133 |
33372179 | Neonatal hyperoxia enhances age-dependent expression of SARS-CoV-2 receptors in mice. | 2020 Dec 28 |
1 |
| 134 |
33375616 | Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy. | 2020 Dec 25 |
2 |
| 135 |
33382023 | Fisetin 8-C-glucoside as entry inhibitor in SARS CoV-2 infection: molecular modelling study. | 2020 Dec 31 |
2 |
| 136 |
33391794 | ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study. | 2020 Nov |
1 |
| 137 |
33415017 | Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease. | 2020 |
1 |
| 138 |
33488517 | The Adrenal Cortex, an Underestimated Site of SARS-CoV-2 Infection. | 2020 |
1 |
| 139 |
30626688 | TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection. | 2019 Mar 15 |
3 |
| 140 |
11741986 | Spinesin/TMPRSS5, a novel transmembrane serine protease, cloned from human spinal cord. | 2002 Mar 1 |
1 |